These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 324222)

  • 21. The mechanism of cell surface changes of guinea pig macrophages activated with purified migration inhibitory factor/macrophage activation factor.
    Homma Y; Onozaki K; Fukutomi Y; Hashimoto T
    Cell Immunol; 1982 Sep; 72(2):231-8. PubMed ID: 6185234
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of oxytocin on fibrinolysis and the status of the kallikrein-kinin system].
    Kirichuk VF; Burova MB
    Probl Endokrinol (Mosk); 1989; 35(2):81-4. PubMed ID: 2740321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the concentration of inducing agent on the output of lymphokines in the guinea pig.
    Ford WH; Ashworth LA; Inder S
    Eur J Immunol; 1976 Feb; 6(2):135-8. PubMed ID: 786697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
    Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
    Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of soluble lymphocyte mediators. IV. Effect of migratio inhibitory factor (MIF) on macrophage cyclic AMP and on responsiveness to adenylate cyclase stimulators.
    Pick E
    Cell Immunol; 1977 Aug; 32(2):329-39. PubMed ID: 198144
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage activation induced by lymphocyte mediators.
    David JR
    Acta Endocrinol Suppl (Copenh); 1975; 194():245-61. PubMed ID: 1092116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.
    Center DM; Cruikshank W
    J Immunol; 1982 Jun; 128(6):2563-8. PubMed ID: 7042840
    [No Abstract]   [Full Text] [Related]  

  • 31. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP.
    Bendtzen K
    Biochim Biophys Acta; 1979 Jan; 566(1):183-91. PubMed ID: 215234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human leucocyte response to migration inhibitory activity from lymphocytes. Modification by aprotinin, Tranexamic acid and phenylmethyl sulfonylfluoride.
    Coeugniet E; Søeberg B; Bendixen G
    Acta Med Scand; 1978; 203(3):191-5. PubMed ID: 305717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
    Górski AJ; Dupont B; Hansen JA; Good RA
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of [ethyl p-(6-guanidinohexanoyloxy)benzoate] methanesulfonate (FOY) on kinin formation and fibrinolysis activity].
    Aishita H; Okegawa T; Akimoto A; Makita T; Shimizu H
    Nihon Yakurigaku Zasshi; 1975 Jan; 71(1):89-99. PubMed ID: 169189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of action of soluble lymphocyte mediators. V. Mechanism of refractoriness to adenylate cyclase stimulators induced by migration inhibitory factor (MIF).
    Pick E; Grunspan-Swirsky A
    Cell Immunol; 1977 Aug; 32(2):340-9. PubMed ID: 198145
    [No Abstract]   [Full Text] [Related]  

  • 38. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphokine-mediated stimulation of eosinophil migration in the guinea-pig.
    van den Berg WB; van Tuyl J; Sminia P; Jentjens TM; Scheper RJ
    Immunology; 1981 Nov; 44(3):481-8. PubMed ID: 7319548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphokine-mediated fusion and migration inhibition of alveolar macrophages.
    Warfel AH; Hadden JW
    Exp Mol Pathol; 1980 Oct; 33(2):153-68. PubMed ID: 6998722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.